欧洲阿片类药物市场预测至 2030 年 - 区域分析 - 按产品（速释短效阿片类药物和缓释长效阿片类药物）、应用（疼痛管理、麻醉、腹泻抑制、咳嗽抑制、脱瘾等）、给药途径（口服、注射和透皮贴剂）和分销渠道（医院药房和零售药房）

Historic Data: 2020-2021   |   Base Year: 2022   |   Forecast Period: 2023-2030

No. of Pages: 90    |    Report Code: BMIRE00030996    |    Category: Life Sciences

Available Report Formats

pdf-format excel-format pptx-format
Request Free Sample Buy Now
Europe Opioids Market
Free Sample Buy Now
2022 年欧洲阿片类药物市场价值为 45.5386 亿美元，预计到 2030 年将达到 52.3772 亿美元；预计 2022 年至 2030 年的复合年增长率为 1.8%。

慢性疼痛发病率飙升推动欧洲阿片类药物市场发展

心血管疾病、癌症、肌肉骨骼疾病和神经血管疾病等慢性疾病会降低免疫力，严重影响人体健康。此外，许多患有这些疾病的患者都会经历慢性疼痛。上述疾病在成人和老年人群中最常见。然而，这些疾病的病例在儿童中也明显增加。慢性疼痛在运动员、运动员和过去受过伤的人中也很常见。根据美国国家生物技术信息中心 (NCBI) 发表的一项研究，全球有 20% 的成年人患有疼痛，每年有 10% 的人新诊断出患有慢性疼痛。尽管疼痛影响所有人群，无论性别、种族/民族、收入、年龄或地理位置如何，但疼痛在世界各地的分布并不均匀。处方阿片类药物，包括氢可酮、羟可酮和吗啡，是有效的止痛药，用于治疗由受伤、手术和癌症、关节炎等健康状况引起的疼痛。阿片类药物处方量的增加可以归因于保险报销计划，该计划鼓励人们使用阿片类药物而不是替代性疼痛治疗，成本结构鼓励更有效的护理，以及将患者满意度与有效疼痛管理相结合的评估。因此，由于阿片类药物在疼痛管理方面的优势，慢性病患者的需求正在上升。

欧洲阿片类药物市场概览

欧洲阿片类药物市场分为德国、英国、法国、意大利、西班牙和欧洲其他地区。欧洲在欧洲阿片类药物市场中占有重要地位，预计在预测期内将经历强劲的市场增长。该地区的市场增长主要归因于导致慢性疼痛的疾病（如关节炎、下背痛和纤维肌痛）的患病率上升，以及用于治疗阿片类药物成瘾（如海洛因）的药物供应激增。例如，美沙酮是欧洲最常用的阿片类药物激动剂，75% 的患者将其用于阿片类药物激动剂维持治疗。丁丙诺啡是该地区第二大使用的阿片类药物激动剂。然而，它是克罗地亚、塞浦路斯、捷克共和国、芬兰、法国和瑞典最常用的阿片类药物维持治疗之一。可待因是塞浦路斯和德国使用的主要激动剂，而二乙酰吗啡是比利时、丹麦、德国、荷兰、西班牙、英国和爱尔兰常用的激动剂。

欧洲阿片类药物市场收入及预测至 2030 年（百万美元）

欧洲阿片类药物市场细分

欧洲阿片类药物市场分为产品、应用、给药途径、分销渠道和国家。

根据产品，欧洲阿片类药物市场分为速释短效阿片类药物和缓释长效阿片类药物。速释短效阿片类药物部分在 2022 年占据了更大的市场份额。速释短效阿片类药物进一步细分为羟可酮、氢可酮、曲马多、可待因、丙氧芬等。缓释长效阿片类药物进一步细分为羟可酮、芬太尼、吗啡、美沙酮等。

在应用方面，欧洲阿片类药物市场分为疼痛管理、麻醉、腹泻抑制、咳嗽抑制、脱瘾等。疼痛管理部分在 2022 年占据了最大的市场份额。

按给药途径，欧洲阿片类药物市场细分为口服、注射和透皮贴剂。口服部分在 2022 年占据了最大的市场份额。

按分销渠道，欧洲阿片类药物市场分为医院药房和零售药房。医院药房部分在 2022 年占据了更大的市场份额。

按国家/地区，欧洲阿片类药物市场细分为英国、德国、法国、意大利、西班牙和欧洲其他地区。 2022 年，英国占据了欧洲阿片类药物市场的主导份额。

Endo International plc、Mallinckrodt Plc、Neuraxpharm Pharmaceuticals SL、Hikma Pharmaceuticals Plc、Rusan Pharma Ltd 和 Teva Pharmaceutical Industries Ltd 是欧洲阿片类药物市场的一些领先公司。

Europe Opioids Strategic Insights

Strategic insights for Europe Opioids involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.

strategic-framework/europe-opioids-market-strategic-framework.webp
Get more information on this report

Europe Opioids Report Scope

Report Attribute Details
Market size in 2022 US$ 4,553.86 Million
Market Size by 2030 US$ 5,237.72 Million
Global CAGR (2022 - 2030) 1.8%
Historical Data 2020-2021
Forecast period 2023-2030
Segments Covered By 产品
  • 速释短效阿片类药物
  • 缓释长效阿片类药物
By 应用
  • 疼痛管理
  • 麻醉
  • 止泻
  • 止咳
  • 戒毒
By 给药途径
  • 口服
  • 注射
  • 透皮贴剂
By 分销渠道
  • 医院药房
  • 零售药房
Regions and Countries Covered 欧洲
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 意大利
  • 欧洲其他地区
Market leaders and key company profiles
  • Endo International plc
  • Mallinckrodt Plc
  • Neuraxpharm Pharmaceuticals SL
  • Hikma Pharmaceuticals Plc
  • Rusan Pharma Ltd
  • Teva Pharmaceutical Industries Ltd
    		•
    Get more information on this report

    Europe Opioids Regional Insights

    The regional scope of Europe Opioids refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.

    geography/europe-opioids-market-geography.webp
    Get more information on this report
    Identical Market Reports with other Region/Countries

    The List of Companies - Europe Opioids Market

    1. Endo International plc
    2. Mallinckrodt Plc
    3. Neuraxpharm Pharmaceuticals SL
    4. Hikma Pharmaceuticals Plc
    5. Rusan Pharma Ltd
    6. Teva Pharmaceutical Industries Ltd
    Frequently Asked Questions
    How big is the Europe Opioids Market?

    The Europe Opioids Market is valued at US$ 4,553.86 Million in 2022, it is projected to reach US$ 5,237.72 Million by 2030.

    What is the CAGR for Europe Opioids Market by (2022 - 2030)?

    As per our report Europe Opioids Market, the market size is valued at US$ 4,553.86 Million in 2022, projecting it to reach US$ 5,237.72 Million by 2030. This translates to a CAGR of approximately 1.8% during the forecast period.

    What segments are covered in this report?

    The Europe Opioids Market report typically cover these key segments-

  • 产品 (速释短效阿片类药物, 缓释长效阿片类药物)
  • 应用 (疼痛管理, 麻醉, 止泻, 止咳, 戒毒)
  • 给药途径 (口服, 注射, 透皮贴剂)

    • What is the historic period, base year, and forecast period taken for Europe Opioids Market?

    The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Europe Opioids Market report:

  • Historic Period : 2020-2021
  • Base Year : 2022
  • Forecast Period : 2023-2030
    • Who are the major players in Europe Opioids Market?

    The Europe Opioids Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:

  • Endo International plc
  • Mallinckrodt Plc
  • Neuraxpharm Pharmaceuticals SL
  • Hikma Pharmaceuticals Plc
  • Rusan Pharma Ltd
  • Teva Pharmaceutical Industries Ltd
    • Who should buy this report?

    The Europe Opioids Market report is valuable for diverse stakeholders, including:

    • Investors: Provides insights for investment decisions pertaining to market growth, companies, or industry insights. Helps assess market attractiveness and potential returns.
    • Industry Players: Offers competitive intelligence, market sizing, and trend analysis to inform strategic planning, product development, and sales strategies.
    • Suppliers and Manufacturers: Helps understand market demand for components, materials, and services related to concerned industry.
    • Researchers and Consultants: Provides data and analysis for academic research, consulting projects, and market studies.
    • Financial Institutions: Helps assess risks and opportunities associated with financing or investing in the concerned market.

    Essentially, anyone involved in or considering involvement in the Europe Opioids Market value chain can benefit from the information contained in a comprehensive market report.

    europe-opioids-market